vs

Side-by-side financial comparison of ARGENX SE (ARGX) and QVC Group, Inc. (QVCGA). Click either name above to swap in a different company.

QVC Group, Inc. is the larger business by last-quarter revenue ($2.7B vs $2.5B, roughly 1.1× ARGENX SE). ARGENX SE runs the higher net margin — 35.5% vs -1.4%, a 36.8% gap on every dollar of revenue. On growth, ARGENX SE posted the faster year-over-year revenue change (83.2% vs -9.1%). ARGENX SE produced more free cash flow last quarter ($322.4M vs $191.0M).

AbbVie Inc. is an American pharmaceutical company headquartered in North Chicago, Illinois. They have produced drugs to treat a wide range of medical issues.

QVC Group, is an American media conglomerate controlled by company chairman John C. Malone, who owns a majority of the voting shares.

ARGX vs QVCGA — Head-to-Head

Bigger by revenue
QVCGA
QVCGA
1.1× larger
QVCGA
$2.7B
$2.5B
ARGX
Growing faster (revenue YoY)
ARGX
ARGX
+92.3% gap
ARGX
83.2%
-9.1%
QVCGA
Higher net margin
ARGX
ARGX
36.8% more per $
ARGX
35.5%
-1.4%
QVCGA
More free cash flow
ARGX
ARGX
$131.4M more FCF
ARGX
$322.4M
$191.0M
QVCGA

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ARGX
ARGX
QVCGA
QVCGA
Revenue
$2.5B
$2.7B
Net Profit
$877.2M
$-37.0M
Gross Margin
89.5%
32.9%
Operating Margin
28.9%
3.7%
Net Margin
35.5%
-1.4%
Revenue YoY
83.2%
-9.1%
Net Profit YoY
1.3%
97.1%
EPS (diluted)
$13.25
$-17.37

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ARGX
ARGX
QVCGA
QVCGA
Q4 25
$2.5B
$2.7B
Q3 25
$2.2B
Q2 25
$1.8B
$2.2B
Q1 25
$2.1B
Q4 24
$1.4B
$2.9B
Q3 24
$2.3B
Q2 24
$901.9M
$2.4B
Q1 24
$2.3B
Net Profit
ARGX
ARGX
QVCGA
QVCGA
Q4 25
$877.2M
$-37.0M
Q3 25
$-80.0M
Q2 25
$414.8M
$-2.2B
Q1 25
$-100.0M
Q4 24
$865.6M
$-1.3B
Q3 24
$-23.0M
Q2 24
$-32.5M
$20.0M
Q1 24
$-1.0M
Gross Margin
ARGX
ARGX
QVCGA
QVCGA
Q4 25
89.5%
32.9%
Q3 25
34.0%
Q2 25
89.2%
36.4%
Q1 25
34.2%
Q4 24
90.2%
33.3%
Q3 24
35.3%
Q2 24
89.4%
36.4%
Q1 24
35.5%
Operating Margin
ARGX
ARGX
QVCGA
QVCGA
Q4 25
28.9%
3.7%
Q3 25
2.7%
Q2 25
19.2%
-101.6%
Q1 25
0.7%
Q4 24
8.7%
-43.2%
Q3 24
6.5%
Q2 24
-15.4%
6.9%
Q1 24
6.2%
Net Margin
ARGX
ARGX
QVCGA
QVCGA
Q4 25
35.5%
-1.4%
Q3 25
-3.6%
Q2 25
23.4%
-99.4%
Q1 25
-4.8%
Q4 24
64.1%
-43.7%
Q3 24
-1.0%
Q2 24
-3.6%
0.8%
Q1 24
-0.0%
EPS (diluted)
ARGX
ARGX
QVCGA
QVCGA
Q4 25
$13.25
$-17.37
Q3 25
$-9.89
Q2 25
$6.32
$-275.46
Q1 25
$-0.25
Q4 24
$13.33
Q3 24
$-0.06
Q2 24
$-0.55
$2.57
Q1 24

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ARGX
ARGX
QVCGA
QVCGA
Cash + ST InvestmentsLiquidity on hand
$3.5B
$2.0B
Total DebtLower is stronger
$790.0M
Stockholders' EquityBook value
$7.3B
$-3.1B
Total Assets
$8.7B
$7.6B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ARGX
ARGX
QVCGA
QVCGA
Q4 25
$3.5B
$2.0B
Q3 25
$1.8B
Q2 25
$2.1B
$897.0M
Q1 25
$833.0M
Q4 24
$1.5B
$905.0M
Q3 24
$873.0M
Q2 24
$1.4B
$1.2B
Q1 24
$1.1B
Total Debt
ARGX
ARGX
QVCGA
QVCGA
Q4 25
$790.0M
Q3 25
$5.9B
Q2 25
$4.9B
Q1 25
$5.0B
Q4 24
$4.1B
Q3 24
$5.1B
Q2 24
$11.0M
$5.3B
Q1 24
$5.5B
Stockholders' Equity
ARGX
ARGX
QVCGA
QVCGA
Q4 25
$7.3B
$-3.1B
Q3 25
$-3.1B
Q2 25
$6.1B
$-3.0B
Q1 25
$-981.0M
Q4 24
$5.5B
$-971.0M
Q3 24
$397.0M
Q2 24
$4.3B
$328.0M
Q1 24
$255.0M
Total Assets
ARGX
ARGX
QVCGA
QVCGA
Q4 25
$8.7B
$7.6B
Q3 25
$7.6B
Q2 25
$7.2B
$6.7B
Q1 25
$9.0B
Q4 24
$6.2B
$9.2B
Q3 24
$10.8B
Q2 24
$4.8B
$10.9B
Q1 24
$11.0B
Debt / Equity
ARGX
ARGX
QVCGA
QVCGA
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
12.74×
Q2 24
0.00×
16.28×
Q1 24
21.53×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ARGX
ARGX
QVCGA
QVCGA
Operating Cash FlowLast quarter
$323.3M
$244.0M
Free Cash FlowOCF − Capex
$322.4M
$191.0M
FCF MarginFCF / Revenue
13.0%
7.1%
Capex IntensityCapex / Revenue
0.0%
2.0%
Cash ConversionOCF / Net Profit
0.37×
TTM Free Cash FlowTrailing 4 quarters
$594.5M
$118.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ARGX
ARGX
QVCGA
QVCGA
Q4 25
$323.3M
$244.0M
Q3 25
$4.0M
Q2 25
$361.8M
$86.0M
Q1 25
$-60.0M
Q4 24
$41.9M
$212.0M
Q3 24
$20.0M
Q2 24
$-124.7M
$267.0M
Q1 24
$26.0M
Free Cash Flow
ARGX
ARGX
QVCGA
QVCGA
Q4 25
$322.4M
$191.0M
Q3 25
$-27.0M
Q2 25
$356.6M
$48.0M
Q1 25
$-94.0M
Q4 24
$40.9M
$150.0M
Q3 24
$-23.0M
Q2 24
$-125.5M
$213.0M
Q1 24
$-14.0M
FCF Margin
ARGX
ARGX
QVCGA
QVCGA
Q4 25
13.0%
7.1%
Q3 25
-1.2%
Q2 25
20.1%
2.1%
Q1 25
-4.5%
Q4 24
3.0%
5.1%
Q3 24
-1.0%
Q2 24
-13.9%
8.8%
Q1 24
-0.6%
Capex Intensity
ARGX
ARGX
QVCGA
QVCGA
Q4 25
0.0%
2.0%
Q3 25
1.4%
Q2 25
0.3%
1.7%
Q1 25
1.6%
Q4 24
0.1%
2.1%
Q3 24
1.8%
Q2 24
0.1%
2.2%
Q1 24
1.7%
Cash Conversion
ARGX
ARGX
QVCGA
QVCGA
Q4 25
0.37×
Q3 25
Q2 25
0.87×
Q1 25
Q4 24
0.05×
Q3 24
Q2 24
13.35×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ARGX
ARGX

Segment breakdown not available.

QVCGA
QVCGA

Other$915.0M34%
Home$754.0M28%
Beauty$260.0M10%
Apparel$254.0M9%
Electronics$187.0M7%
Accessories$181.0M7%
Jewelry$87.0M3%
Manufactured Product Other$38.0M1%

Related Comparisons